Edition:
United Kingdom

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.96USD
7:02pm GMT
Change (% chg)

$0.04 (+2.08%)
Prev Close
$1.92
Open
$1.91
Day's High
$1.97
Day's Low
$1.91
Volume
601
Avg. Vol
9,686
52-wk High
$3.88
52-wk Low
$1.56

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy December 17 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 0 0 0
(3) HOLD 0 0 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Quarter Ending Jun-19 1 0.00 0.00 0.00 --
Year Ending Dec-19 1 0.00 0.00 0.00 0.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 -0.30 -0.53 0.23 -76.67
Quarter Ending Mar-18 -0.36 -0.09 0.27 -75.00
Quarter Ending Dec-17 -0.66 -1.00 0.34 -51.52
Quarter Ending Sep-17 -0.65 -1.00 0.35 -52.67
Quarter Ending Jun-17 -0.03 0.00 0.03 -100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 0.00 0.00 -- -- --
Quarter Ending Jun-19 0.00 0.00 -- -- --
Year Ending Dec-19 0.00 0.00 -- 0.00 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 -- --
Quarter Ending Jun-19 0 0 -- --
Year Ending Dec-19 0 0 -- --
Earnings